Q3 2021 Holdings
Filed 2021-11-15 | 26 holdings | $48.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adagio Therapeutics(IVVD) | Common Stock | 00534A102 | $26.7M | 632,855 | 55.4% |
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $14.9M | 623,836 | 30.9% |
| Atea Pharmaceuticals(AVIR) | Common Stock | 04683R106 | $5.8M | 164,577 | 12.0% |
| Nuvation Bio(NUVB) | Common Stock | 67080N101 | $280.4K | 28,212,376 | 0.6% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $145.1K | 4,896,074 | 0.3% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $80.0K | 3,818,283 | 0.2% |
| Morphic Holding | Common Stock | 61775R105 | $74.5K | 1,315,952 | 0.2% |
| Imago Biosciences | Common Stock | 45250K107 | $60.5K | 3,018,737 | 0.1% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $41.7K | 3,320,608 | 0.1% |
| Ikena Oncology | Common Stock | 45175G108 | $28.4K | 2,249,123 | 0.1% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $21.7K | 2,029,580 | 0.0% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $19.0K | 843,750 | 0.0% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $15.8K | 1,788,160 | 0.0% |
| Spruce Biosciences | Common Stock | 85209E109 | $13.0K | 2,161,022 | 0.0% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $12.7K | 2,606,809 | 0.0% |
| Icosavax | Common Stock | 45114M109 | $12.6K | 426,395 | 0.0% |
| Syros Pharmaceuticals | Common Stock | 87184Q107 | $11.2K | 2,512,705 | 0.0% |
| Checkmate Pharmaceuticals | Common Stock | 162818108 | $5.3K | 1,335,050 | 0.0% |
| Omega Alpha Spac | Common Stock | G6749V107 | $4.9K | 501,000 | 0.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $4.5K | 2,005,249 | 0.0% |
| ObsEva SA | Common Stock | H5861P103 | $3.1K | 999,364 | 0.0% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $2.6K | 328,196 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.0K | 275,513 | 0.0% |
| Immunocore Holdings(IMCR) | Common Stock | 45258D105 | $1.9K | 51,535 | 0.0% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $1.8K | 1,263,408 | 0.0% |
| FibroGen Inc(FGENEUR) | Common Stock | 31572Q808 | $1.2K | 130,646 | 0.0% |